Assessment of The Bethesda System for Reporting Thyroid Cytopathology: Surgical and long-term clinical follow-up of 2,893 thyroid fine-needle aspirations
JL Sauter, H Lehrke, X Zhang… - American journal of …, 2019 - academic.oup.com
JL Sauter, H Lehrke, X Zhang, OT Al Badri, R Rodriguez-Gutierrez, DA Delivanis…
American journal of clinical pathology, 2019•academic.oup.comObjectives Long-term follow-up is important for determining performance characteristics of
thyroid fine-needle aspiration (FNA). Methods Histologic or 3 or more years of clinical follow-
up was used to calculate performance characteristics of thyroid FNA before and after
implementation of The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC).
The impact of noninvasive follicular thyroid neoplasm with papillary-like nuclear features
(NIFTP) classification was also investigated. Results Follow-up was obtained for 1,277/1,134 …
thyroid fine-needle aspiration (FNA). Methods Histologic or 3 or more years of clinical follow-
up was used to calculate performance characteristics of thyroid FNA before and after
implementation of The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC).
The impact of noninvasive follicular thyroid neoplasm with papillary-like nuclear features
(NIFTP) classification was also investigated. Results Follow-up was obtained for 1,277/1,134 …
Objectives
Long-term follow-up is important for determining performance characteristics of thyroid fine-needle aspiration (FNA).
Methods
Histologic or 3 or more years of clinical follow-up was used to calculate performance characteristics of thyroid FNA before and after implementation of The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC). The impact of noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) classification was also investigated.
Results
Follow-up was obtained for 1,277/1,134 and 1,616/1,393 aspirates/patients (median clinical follow-up, 9.9 and 4.4 years, pre- and post-TBSRTC, respectively). Nondiagnostic, suspicious for follicular neoplasm, and suspicious for malignancy (SFM) diagnoses decreased and benign diagnoses increased post-TBSRTC, while atypical rate remained less than 1%. Negative predictive value for benign nodules and positive predictive value (PPV) for SFM increased significantly. Eleven nodules were reclassified as NIFTP, slightly decreasing PPV/risk of malignancy (ROM).
Conclusions
Appropriate ROM for thyroid FNA can be achieved through application of TBSRTC terminology with minimal use of atypical category.
Oxford University Press
以上显示的是最相近的搜索结果。 查看全部搜索结果